Singapore markets closed

Corbus Pharmaceuticals Holdings, Inc. (0SZI.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
45.41-0.28 (-0.60%)
At close: 06:27PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.47
52-week change 3877.50%
S&P500 52-week change 326.49%
52-week high 349.65
52-week low 32.82
50-day moving average 321.54
200-day moving average 310.76

Share statistics

Avg vol (3-month) 33.32k
Avg vol (10-day) 33.92k
Shares outstanding 557.24M
Implied shares outstanding 6N/A
Float 87.56M
% held by insiders 10.68%
% held by institutions 193.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.033333:1
Last split date 314 Feb 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-26.36%
Return on equity (ttm)-59.52%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -36.78M
Net income avi to common (ttm)-33.76M
Diluted EPS (ttm)-0.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)120.1M
Total cash per share (mrq)11.43
Total debt (mrq)17.29M
Total debt/equity (mrq)17.83%
Current ratio (mrq)4.69
Book value per share (mrq)9.23

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A